Title : The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.

Pub. Date : 2018 Jun

PMID : 29624862






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Using NIH 3T3 BRAFV600E fibroblasts and the melanoma cell lines A375 and M238 carrying the same BRAF mutation, we show that under treatment with the ROS-inducing agent phenethyl isothiocyanate (PEITC), oncogenic BRAF renders cells refractory to p66ShcS36 phosphorylation, which is essential for p66Shc activation and mitochondrial ROS production. phenethyl isothiocyanate Braf transforming gene Mus musculus
2 Using NIH 3T3 BRAFV600E fibroblasts and the melanoma cell lines A375 and M238 carrying the same BRAF mutation, we show that under treatment with the ROS-inducing agent phenethyl isothiocyanate (PEITC), oncogenic BRAF renders cells refractory to p66ShcS36 phosphorylation, which is essential for p66Shc activation and mitochondrial ROS production. phenethyl isothiocyanate Braf transforming gene Mus musculus